Maternal Physiological Changes — MCQs
Compared to a pregnant female, a lactating female would require a higher level of nutrient supplementation for which of the following?
Milk production in pregnancy is inhibited by :
All are cardiovascular system changes in pregnancy except.
Cardiac output in pregnancy shows significant increase from which week of gestation
Which physiological adaptation does not happen at high altitudes?
Placenta grade 3, 35+3 weeks pregnancy, and absent end diastolic flow Doppler; next management is:
The net effect of antenatal care has been the following EXCEPT:
Newborns typically lose how much weight in the first week?
Anti-D Rh immunoglobulin is indicated in which of the following situations?
What is the approximate recurrence risk for neural tube defects (NTDs) in a subsequent pregnancy, given that the first baby was born with an NTD?
Maternal Physiological Changes Indian Medical PG Practice Questions and MCQs
Question 1: Compared to a pregnant female, a lactating female would require a higher level of nutrient supplementation for which of the following?
- A. Calcium (Correct Answer)
- B. Folic acid
- C. Iron
- D. Vitamin A
Explanation: ***Calcium*** - **Lactating women** require higher calcium intake compared to pregnant women due to significant calcium transfer into **breast milk** for infant bone development. - This increased demand helps maintain maternal bone density and ensures adequate calcium supply for the baby. *Folic acid* - **Folic acid** is critically important during **pregnancy** to prevent neural tube defects, with supplementation typically decreasing postpartum. - While still necessary, the daily recommended intake for lactating women is generally lower than during pregnancy. *Iron* - **Iron requirements** are highest during **pregnancy** to support increased maternal blood volume and fetal development. - In lactating women, iron needs often decrease postpartum, especially if there was minimal blood loss during delivery and menstruation has not yet resumed. *Vitamin A* - While **Vitamin A** is important for both pregnant and lactating women, the recommended intake for pregnant women tends to be slightly higher, especially for **fetal organ development**. - Excessive vitamin A can be teratogenic during pregnancy, so supplementation needs careful monitoring in both states.
Question 2: Milk production in pregnancy is inhibited by :
- A. Low luteinizing hormone
- B. Low thyroid-stimulating hormone
- C. High estrogen (Correct Answer)
- D. Human somatomammotropin
Explanation: ***High estrogen*** - High levels of **estrogen** and progesterone during pregnancy inhibit milk production by blocking the action of **prolactin** on the mammary glands. - After delivery, the sudden drop in these hormones removes the inhibition, allowing prolactin to stimulate **lactogenesis**. *Low luteinizing hormone* - **Luteinizing hormone (LH)** is primarily involved in ovulation and corpus luteum formation, not directly in the inhibition of milk production. - Low LH levels would impact fertility but not have a direct inhibitory effect on lactation. *Low thyroid-stimulating hormone* - **Thyroid-stimulating hormone (TSH)** regulates thyroid function, which can indirectly affect metabolism and overall well-being. - While **hypothyroidism** can impact milk supply, low TSH itself is not a direct inhibitor of milk production. *Human somatomammotropin* - **Human placental lactogen (HPL)**, also known as human chorion somatomammotropin, is produced by the placenta. - It promotes mammary gland development and has weak lactogenic properties but does not inhibit milk production.
Question 3: All are cardiovascular system changes in pregnancy except.
- A. Increase in blood volume
- B. Increase in heart rate
- C. Increase in peripheral resistance (Correct Answer)
- D. Increase in cardiac output
Explanation: ***Increase in peripheral resistance*** - During normal pregnancy, **peripheral vascular resistance actually decreases** due to the effects of hormones like progesterone and the presence of the low-resistance uteroplacental circulation. - This decrease in resistance helps accommodate the increased blood volume and cardiac output. *Increase in cardiac output* - **Cardiac output increases significantly** during pregnancy (by 30-50%) to meet the metabolic demands of the growing fetus and maternal tissues. - This is primarily achieved through an increase in both stroke volume and heart rate. *Increase in blood volume* - **Blood volume increases substantially** (by 30-50%) during pregnancy, with plasma volume increasing more than red blood cell mass. - This expansion supports the increased cardiac output and placental perfusion. *Increase in heart rate* - **Heart rate increases** during pregnancy, typically by 10-20 beats per minute, contributing to the overall increase in cardiac output. - This physiological adaptation helps maintain adequate circulation.
Question 4: Cardiac output in pregnancy shows significant increase from which week of gestation
- A. 25 weeks
- B. 35 weeks
- C. 5 weeks
- D. 15 weeks (Correct Answer)
Explanation: ***15 weeks*** - Cardiac output shows a **significant and clinically measurable increase around 10-15 weeks of gestation**, which continues to rise, peaking between **20-28 weeks**. - This rise is primarily due to an increase in both **stroke volume** (increased by 25-30%) and **heart rate** (increased by 10-15 bpm) to meet the metabolic demands of the growing fetus and placenta. - By 15 weeks, cardiac output has typically increased by approximately **20-30% above pre-pregnancy levels**. *5 weeks* - While cardiac output does begin to rise very early in pregnancy (as early as 5-8 weeks), the increase at this stage is **subtle and not yet significant**. - At 5 weeks, the **placental circulation is still in early development**, and the hemodynamic changes are just beginning. - The question asks about **significant increase**, which is not yet established at 5 weeks. *25 weeks* - By 25 weeks, cardiac output has already completed its major rise and is at or near its **peak levels** (40-50% above baseline). - The **significant increase had already occurred** much earlier, around 10-15 weeks. - This timing represents the plateau phase rather than the initial significant increase. *35 weeks* - At 35 weeks, cardiac output remains elevated at near-peak levels but the **major increase happened much earlier** in pregnancy. - By this gestational age, the cardiovascular system has been adapted for months. - There may be minor positional variations (e.g., aortocaval compression in supine position) but no new significant increase occurs.
Question 5: Which physiological adaptation does not happen at high altitudes?
- A. Pulmonary vasoconstriction
- B. Respiratory acidosis (Correct Answer)
- C. Hypoxia
- D. Polycythemia
Explanation: ***Respiratory acidosis*** - At high altitudes, the primary physiological response to **hypoxia** is to increase ventilation, leading to a decrease in **arterial PCO2**. - This reduction in **PCO2** causes **respiratory alkalosis**, not acidosis, as the body tries to compensate for the lower oxygen levels. *Pulmonary vasoconstriction* - This is a significant physiological response to **hypoxia** at high altitudes, leading to an increase in **pulmonary artery pressure**. - Its purpose is to divert blood flow to better-ventilated areas of the lung, but it can also contribute to **pulmonary hypertension**. *Hypoxia* - Reduced **atmospheric pressure** at high altitudes directly results in a lower partial pressure of oxygen (**PO2**), leading to **hypoxia**. - This low **PO2** is the primary trigger for most other physiological adaptations seen at high altitudes. *Polycythemia* - Prolonged exposure to **hypoxia** stimulates the kidneys to release **erythropoietin (EPO)**, which in turn increases **red blood cell production**. - This adaptive increase in **red blood cell count** and **hemoglobin concentration** aims to enhance the oxygen-carrying capacity of the blood.
Question 6: Placenta grade 3, 35+3 weeks pregnancy, and absent end diastolic flow Doppler; next management is:
- A. Monitor
- B. Terminate after 37 weeks
- C. Dexamethasone and terminate after 48 hours (Correct Answer)
- D. Consult pediatrician and plan immediate delivery
Explanation: ***Dexamethasone and terminate after 48 hours*** - Absent end diastolic flow (AEDF) at 35+3 weeks indicates **severe uteroplacental insufficiency** and significant fetal compromise, requiring intervention. - Administering **dexamethasone** (corticosteroids) for 48 hours helps to accelerate **fetal lung maturity** before delivery, reducing the risk of respiratory distress syndrome. *Monitor* - Simply monitoring is an inappropriate and potentially harmful management strategy given the presence of **absent end diastolic flow**, which reflects **critical fetal hypoxia**. - Delaying intervention in cases of AEDF significantly increases the risk of **fetal demise** and severe morbidity. *Terminate after 37 weeks* - Waiting until 37 weeks is too long. **Absent end diastolic flow** at 35+3 weeks significantly increases the risk of **fetal compromise** and death if delivery is delayed. - The goal is to balance the risks of prematurity with the risks of continued intrauterine compromise. *Consult pediatrician and plan immediate delivery* - While immediate delivery might be considered in some scenarios of fetal distress, delivering without prior **corticosteroid administration** (dexamethasone) at 35+3 weeks would increase the risk of **neonatal respiratory distress syndrome**. - The 48-hour window allows for **fetal lung maturation** while still addressing the urgent need for delivery due to AEDF.
Question 7: The net effect of antenatal care has been the following EXCEPT:
- A. Reduction in maternal morbidity
- B. Reduction in perinatal mortality
- C. Reduction in the incidence of institutional delivery (Correct Answer)
- D. Reduction in maternal mortality
Explanation: ***Reduction in the incidence of institutional delivery*** - Antenatal care aims to increase awareness of safe delivery practices and encourage women to deliver in health facilities, thereby **increasing institutional deliveries**, not reducing them. - Improved access to and understanding of obstetric care through ANC promotes safer childbirth environments. *Reduction in maternal morbidity* - Antenatal care plays a crucial role in the early detection and management of **pregnancy-related complications** such as pre-eclampsia, gestational diabetes, and infections. - This proactive management minimizes the severity and impact of these conditions on maternal health. *Reduction in perinatal mortality* - Regular antenatal visits allow for monitoring of fetal growth and well-being, identification of **fetal distress**, and intervention for conditions like intrauterine growth restriction. - Early detection and management of issues affecting the fetus significantly improve perinatal outcomes and reduce **stillbirths** and **neonatal deaths**. *Reduction in maternal mortality* - ANC provides essential health education, nutritional advice, and timely vaccinations, which are vital for a healthy pregnancy. - It also facilitates preparedness for childbirth and potential complications, thereby **reducing the risk of maternal death** from preventable causes.
Question 8: Newborns typically lose how much weight in the first week?
- A. 5-10% (Correct Answer)
- B. 1-2%
- C. 11-15%
- D. 15-20%
Explanation: ***5-10%*** - **Physiologic weight loss** of 5-10% of birth weight is normal in newborns during the first week of life. - This loss is primarily due to the **mobilization of extracellular fluid** and delayed onset of full milk production (lactogenesis). - Most infants regain their birth weight by **10-14 days** of age. *1-2%* - A weight loss of only 1-2% in the first week would be **less than expected** and might suggest the infant is retaining excess fluid. - While not necessarily pathological, it's at the **lower end of the normal range** and less typical than the 5-10% range. *11-15%* - A weight loss greater than **10%** is generally considered **excessive** and indicates inadequate feeding or possible dehydration. - Weight loss of 11-15% typically requires **closer monitoring**, feeding assessment, and possible lactation support or supplementation. *15-20%* - A weight loss of 15-20% is significantly **above the normal physiological range** and represents a serious concern for **severe dehydration** or inadequate nutritional intake. - This degree of weight loss would warrant **immediate medical evaluation** and intervention, including possible hospitalization.
Question 9: Anti-D Rh immunoglobulin is indicated in which of the following situations?
- A. Rh positive father, Rh positive mother
- B. Rh negative father, Rh positive mother
- C. Rh negative father, Rh negative mother
- D. Rh positive father, Rh negative mother (Correct Answer)
Explanation: **Explanation:** The primary objective of administering **Anti-D Rh immunoglobulin** is to prevent **Rh isoimmunization** (Rh sensitization). This condition occurs when an Rh-negative mother is exposed to Rh-positive fetal red blood cells, leading to the production of maternal antibodies that can cause Hemolytic Disease of the Fetus and Newborn (HDFN) in subsequent pregnancies. **Why Option D is Correct:** For Rh isoimmunization to occur, there must be **Rh feto-maternal incompatibility**. This is only possible if the **mother is Rh-negative** and the **father is Rh-positive**. If the father is Rh-positive, the fetus has a high probability (50-100%) of being Rh-positive. If fetal Rh-positive blood enters the maternal circulation (e.g., during delivery, miscarriage, or amniocentesis), the mother’s immune system recognizes the D-antigen as foreign and produces antibodies. Anti-D immunoglobulin neutralizes these fetal cells before sensitization occurs. **Why Other Options are Incorrect:** * **Options A & B:** If the **mother is Rh-positive**, she already possesses the D-antigen. Her immune system will not produce antibodies against it; therefore, there is no risk of isoimmunization. * **Option C:** If **both parents are Rh-negative**, the fetus will inevitably be Rh-negative. Since there is no D-antigen present in either the mother or the fetus, no immune response can be triggered. **High-Yield Clinical Pearls for NEET-PG:** * **Standard Dose:** 300 µg (1500 IU) is the standard dose, which can neutralize up to **30 ml** of fetal whole blood (or 15 ml of packed RBCs). * **Routine Timing:** In an unsensitized Rh-negative mother, Anti-D is typically given at **28 weeks** of gestation and again within **72 hours of delivery** (if the neonate is confirmed Rh-positive). * **Kleihauer-Betke Test:** Used to quantify the volume of feto-maternal hemorrhage to determine if additional doses of Anti-D are required. * **Indirect Coombs Test (ICT):** Must be **negative** in the mother before administering Anti-D; a positive ICT indicates that sensitization has already occurred, making Anti-D ineffective.
Question 10: What is the approximate recurrence risk for neural tube defects (NTDs) in a subsequent pregnancy, given that the first baby was born with an NTD?
- A. 2%
- B. 4% (Correct Answer)
- C. 10%
- D. 20%
Explanation: **Explanation:** Neural tube defects (NTDs) follow a **multifactorial inheritance** pattern, meaning they result from a combination of genetic predisposition and environmental factors (most notably folic acid deficiency). **1. Why 4% is correct:** In the general population, the incidence of NTDs is approximately 0.1–0.2% (1 in 1,000). However, once a couple has one child with an NTD (anencephaly, spina bifida, or encephalocele), the risk of recurrence in a subsequent pregnancy increases significantly to approximately **3–5%** (standardized as **4%** for examination purposes). If two previous siblings are affected, the risk rises further to about 10%. **2. Why the other options are incorrect:** * **A (2%):** This underestimates the risk. While recurrence risks vary by geography, 3–5% is the globally accepted range for a single prior affected pregnancy. * **C (10%):** This is the approximate recurrence risk only after **two** previously affected siblings. * **D (20%):** This risk is too high for multifactorial inheritance and would be more characteristic of a high-penetrance autosomal dominant condition. **High-Yield Clinical Pearls for NEET-PG:** * **Prevention:** For the general population, the recommended dose of Folic Acid is **400 mcg (0.4 mg)/day** starting 1 month prior to conception. * **Secondary Prevention (High Risk):** For women with a **previous child with NTD**, the dose is increased to **4 mg/day** (10 times the standard dose). * **Screening:** Maternal Serum Alpha-Fetoprotein (MSAFP) is elevated in open NTDs. The best time for screening is **15–20 weeks** (ideal: 16–18 weeks). * **Diagnosis:** Targeted Level II Ultrasound is the gold standard for detecting structural defects.
Want unlimited practice?
Get full access to all questions, explanations, and performance tracking.
Start For Free